In a career at Franklin Templeton spanning 35 years, Johnson has been a key driver in the company's transformation to what is now one of the largest global...
Culture Biosciences has appointed Beth Thompson-Webb, Chief Commercial Officer at Virica Biotech, as Independent Director to the company’s Board of D...
The 21-valent pneumococcal conjugate vaccine candidate, GBP410 (also known as SP0202), demonstrates positive safety and immunogenicit...
Prior to joining Catalent, Mr. Masanovich served as Executive Vice President & Chief Financial Officer of Tenneco Automotive until it was acquired by A...
CancerVAX, Inc., developer of a breakthrough universal cancer vaccine that uses the body’s immune system to fight cancer, announced that its CE...
In a highly anticipated conversation with BioPharma BoardRoom, Eric Hsu, Director of Key Account Management at Samsung Biologics, shares groundbreaking ins...
- Biogen Inc. (Nasdaq: BIIB) announced several changes to its Board of Directors . The changes will refresh the composition of the Board and follow th...
Illumina's Board said it is appreciative of Mr. deSouza's contributions and commitment to the company and all of its stakeholders. "We thank Francis for h...
Merck, a leading science and technology company, today announced that 43 abstracts covering several modalities and mechanisms will be presented at the 2023...
SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company&rsqu...
Ms. Perettie brings with her extensive experience in oncology and a commitment to improving patient care. Most recently, she was Head of Roche’s Mole...
Marcus Kuhnert will step down as Chief Financial Officer and Member of the Executive Board after a successful nine-year tenure Helene von Roeder appoint...
Exothera Nucleic Acids, the world's first nucleic acid CRDMO to provide continuous RNA manufacturing services from early discovery up to commercial cGMP, a...
Largely driven by increasing incidence of chronic and infectious diseases and growth in biotechnology and pharma industries, the global immunoassay market ...
© 2025 Biopharma Boardroom. All Rights Reserved.